Anti-Diabetic Medication

Anti-Diabetic Medications work by either lowering down blood glucose level or by increasing sensitivity to insulin. Type 1 Diabetes is caused by lack of insulin hence, insulin has to be administered subcutaneously. Type 2 Diabetes is treated by oral hypoglycemic agents which act either by (a) increasing the amount of insulin secreted by the pancreas, (b) increasing the sensitivity of target organs to insulin or (c) decreasing the rate at which glucose is absorbed from the gastrointestinal tract.

  • Human Recombinant Insulin
  • Biguanides
  • Sulphonylureas
  • Meglitinides
  • Thiazolidinediones
  • Alpha-Glucosidase Inhibitors
  • Incretin Agonists

Related Conference of Anti-Diabetic Medication

November 11-12, 2019

Annual Congress on Diabetes, Metabolism and Obesity

Sydney, Australia
December 04-05, 2019

3rd Annual Congress on Diabetes and Its Complications

Tokyo, Japan
December 9,10,2019

International Congress and Expo on Diabetic Care

Bangkok,Thailand
December 12-13, 2019

Annual Congress on Diabetes and Endocrinology

Dubai, UAE
January 27-28, 2020

Global Summit On Diabetes & Endocrinology

Bangkok, Thailand
March 25-26, 2020

29th World Diabetes & Heart Congress

| Radisson Narita | Tokyo, Japan
March 27-28, 2020

Annual Summit on Metabolomics

Amsterdam, Netherlands
April 17-18, 2020

3rd Global Meeting on Diabetes and Endocrinology

Kualalumpur, Malaysia
June 15-16, 2020

29thEuropean Diabetes Congress

| Barcelona, Spain
August 17-18, 2020

16th World Congress on Endocrinology & Diabetes

| Copenhagen, Denmark
June 14-15, 2021

diabetic 2021

Abu Dhabi, UAE

Anti-Diabetic Medication Conference Speakers

Recommended Sessions

Related Journals

Are you interested in